105 related articles for article (PubMed ID: 11862219)
1. Down-regulation of diabetogenic CD4+ T cells by a soluble dimeric peptide-MHC class II chimera.
Casares S; Hurtado A; McEvoy RC; Sarukhan A; von Boehmer H; Brumeanu TD
Nat Immunol; 2002 Apr; 3(4):383-91. PubMed ID: 11862219
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of clonal deletion vs. anergy of self-reactive CD4 T-cells for the prevention and reversal of autoimmune diabetes.
Preda-Pais A; Stan AC; Casares S; Bona C; Brumeanu TD
J Autoimmun; 2005 Aug; 25(1):21-32. PubMed ID: 16005609
[TBL] [Abstract][Full Text] [Related]
3. A peptide-major histocompatibility complex II chimera favors survival of pancreatic beta-islets grafted in type 1 diabetic mice.
Casares S; Lin M; Zhang N; Teijaro JR; Stoica C; McEvoy R; Farber DL; Bona C; Brumeanu TD
Transplantation; 2008 Jun; 85(12):1717-25. PubMed ID: 18580462
[TBL] [Abstract][Full Text] [Related]
4. Reversal of type 1 diabetes by a new MHC II-peptide chimera: "Single-epitope-mediated suppression" to stabilize a polyclonal autoimmune T-cell process.
Lin M; Stoica-Nazarov C; Surls J; Kehl M; Bona C; Olsen C; Brumeanu TD; Casares S
Eur J Immunol; 2010 Aug; 40(8):2277-88. PubMed ID: 20540111
[TBL] [Abstract][Full Text] [Related]
5. Antigen-specific downregulation of T cells by doxorubicin delivered through a recombinant MHC II--peptide chimera.
Casares S; Stan AC; Bona CA; Brumeanu TD
Nat Biotechnol; 2001 Feb; 19(2):142-7. PubMed ID: 11175728
[TBL] [Abstract][Full Text] [Related]
6. Soluble, dimeric HLA DR4-peptide chimeras: an approach for detection and immunoregulation of human type-1 diabetes.
Preda I; McEvoy RC; Lin M; Bona CA; Rapaport R; Brumeanu TD; Casares S
Eur J Immunol; 2005 Sep; 35(9):2762-75. PubMed ID: 16106371
[TBL] [Abstract][Full Text] [Related]
7. Protection against diabetes by MHC heterozygosity and reversal by cyclophosphamide.
Wu AY; Schulman SJ; Marconi LA; Reilly CR; Scott B; Lo D
Cell Immunol; 1998 Mar; 184(2):112-20. PubMed ID: 9630837
[TBL] [Abstract][Full Text] [Related]
8. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
[TBL] [Abstract][Full Text] [Related]
9. Cellular mechanisms involved in experimental insulin-dependent diabetes mellitus.
Radu DL
Roum Arch Microbiol Immunol; 2001; 60(3):203-26. PubMed ID: 12165974
[TBL] [Abstract][Full Text] [Related]
10. Class II peptide multimers: promise for type 1A diabetes?
Eisenbarth GS; Nepom GT
Nat Immunol; 2002 Apr; 3(4):344-5. PubMed ID: 11919577
[No Abstract] [Full Text] [Related]
11. Anergy and suppression regulate CD4(+) T cell responses to a self peptide.
Jordan MS; Riley MP; von Boehmer H; Caton AJ
Eur J Immunol; 2000 Jan; 30(1):136-44. PubMed ID: 10602035
[TBL] [Abstract][Full Text] [Related]
12. Regulation of type 1 diabetes by a self-MHC class II peptide: role of transforming growth factor beta (TGF-beta).
Mukherjee R; Chaturvedi P; Agrawal B; Singh B
Cell Mol Biol (Noisy-le-grand); 2003 Mar; 49(2):159-69. PubMed ID: 12887099
[TBL] [Abstract][Full Text] [Related]
13. Antigen-specific signaling by a soluble, dimeric peptide/major histocompatibility complex class II/Fc chimera leading to T helper cell type 2 differentiation.
Casares S; Zong CS; Radu DL; Miller A; Bona CA; Brumeanu TD
J Exp Med; 1999 Aug; 190(4):543-53. PubMed ID: 10449525
[TBL] [Abstract][Full Text] [Related]
14. Distinct local immunogenic stimuli dictate differential requirements for CD4+ and CD8+ T cell subsets in the pathogenesis of spontaneous autoimmune diabetes.
Rajagopalan G; Mangalam AK; Sen MM; Kudva YC; David CS
Autoimmunity; 2007 Nov; 40(7):489-96. PubMed ID: 17966038
[TBL] [Abstract][Full Text] [Related]
15. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
[TBL] [Abstract][Full Text] [Related]
16. Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice.
You S; Slehoffer G; Barriot S; Bach JF; Chatenoud L
Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14580-5. PubMed ID: 15340148
[TBL] [Abstract][Full Text] [Related]
17. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes.
Herkel J; Jagemann B; Wiegard C; Lazaro JF; Lueth S; Kanzler S; Blessing M; Schmitt E; Lohse AW
Hepatology; 2003 May; 37(5):1079-85. PubMed ID: 12717388
[TBL] [Abstract][Full Text] [Related]
18. A model for antigen-specific T-cell anergy: displacement of CD4-p56(lck) signalosome from the lipid rafts by a soluble, dimeric peptide-MHC class II chimera.
Thomas S; Kumar R; Preda-Pais A; Casares S; Brumeanu TD
J Immunol; 2003 Jun; 170(12):5981-92. PubMed ID: 12794125
[TBL] [Abstract][Full Text] [Related]
19. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
20. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory.
Mortara L; Castellani P; Meazza R; Tosi G; De Lerma Barbaro A; Procopio FA; Comes A; Zardi L; Ferrini S; Accolla RS
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3435-43. PubMed ID: 16740768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
